• About Us
    • Overview
    • Education
    • Mission & History
    • Board of Directors
    • The Campus
    • Careers
  • Our Achievements
    • Overview
    • Cancer
    • Technology
    • Education
    • Our Planet
    • Health & Medicine
    • Physical World
  • Get Involved
    • Overview
    • Partners in Science
    • Estate & Planned Giving
    • Attend an Event
    • Gift Opportunities
  • News & Media
    • Overview
    • News & Media Archive
    • Coronavirus
    • Feature Stories
    • News Releases
    • In The News
    • Video Gallery
    • Ad Campaigns
    • Celebrating Great Minds
  • Blog
  • Contact
  • Donate
Donate
Donate
About Us tri
About Us Overview
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
About Us

Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.

Our Achievements tri
Our Achievements Overview
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Our Achievements

The Weizmann Institute’s fundamental research has led to discoveries and applications with a major impact on the scientific community and on the quality of life for millions worldwide.

Get Involved tri
Get Involved Overview
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
Get Involved

Join a community of dedicated people who share the Weizmann Institute’s commitment to shaping a better world through science.

News & Media tri
News & Media Overview
  • News & Media Archive
  • Coronavirus
  • Feature Stories
  • News Releases
  • In The News
  • Video Gallery
  • Ad Campaigns
  • Celebrating Great Minds
News & Media

Learn about the Weizmann Institute’s latest groundbreaking discoveries and the American Committee’s activities across the country.

Blog tri
  • The Curiosity Review
Blog

Popular science for the curious-minded: The Curiosity Review brings discovery to life.

Contact

Search Results

  • SEARCH BY KEYWORD
  • SEARCH BY TAG
View Articles by Tag:
  • View Articles by Tag
  • Algorithims (6)
  • Alternative energy (27)
  • Alzheimers (44)
  • Archaeology (37)
  • Artificial intelligence (20)
  • Astrophysics (108)
  • Autism (22)
  • Awards (119)
  • Bacteria (107)
  • Behavior (9)
  • Biochemistry (101)
  • Biofuel (7)
  • Biology (309)
  • Biomolecular sciences (7)
  • Blood (43)
  • Brain (175)
  • Cancer (163)
  • Cancer treatment (127)
  • Central nervous system (9)
  • Chemistry (78)
  • Children (7)
  • Circadian clock (1)
  • Climate change (73)
  • Clinical trials (40)
  • Collaborations (19)
  • Community (279)
  • Computers (73)
  • Copaxone (12)
  • Coronavirus (7)
  • Culture (359)
  • Diabetes (32)
  • Earth (74)
  • Education (157)
  • Environment (92)
  • Enzymes (29)
  • Evolution (89)
  • Fertility (20)
  • Fungus (4)
  • Genetics (109)
  • Genomics (3)
  • Heart (5)
  • Heart disease (3)
  • Humanity (83)
  • Immune system (149)
  • Immunology (10)
  • Immunotherapy (34)
  • Inflammation (19)
  • Leadership (114)
  • Leukemia (12)
  • Materials (44)
  • Mathematics (62)
  • Medicine (84)
  • Memory (39)
  • Mental health (58)
  • Metabolism (51)
  • Microbiology (2)
  • Microbiome (10)
  • Molecular cell biology (9)
  • Molecular genetics (61)
  • Multiple sclerosis (12)
  • Nanoscience (33)
  • Nature (4)
  • Neurobiology (2)
  • Neuroscience (207)
  • Nutrition (72)
  • Optics (34)
  • Organs (11)
  • Parkinsons (11)
  • Personalized medicine (5)
  • Philanthropy (148)
  • Physics (139)
  • Plants (56)
  • Proteins (96)
  • Quantum computer (3)
  • Quantum physics (2)
  • Quantum theory (34)
  • Robots (8)
  • Security (21)
  • Senses (115)
  • Sensors (8)
  • Smoking (1)
  • Solar power (19)
  • Space (110)
  • Stem cells (49)
  • Technology (206)
  • Vaccine (40)
  • Virus (135)
  • Water (40)
  • Weather (1)
  • Women (115)
  • World hunger (17)
Filter by Time:
  • All
  • Past Day
  • Past Week
  • Past Month
  • Past Year
  • Past Three Years
Clear Filters

40 results for Clinical trials

Weizmann Institute Drug, TOOKAD® Soluble, Approved in Mexico for Prostate Cancer Therapy
Weizmann Institute Drug, TOOKAD® Soluble, Approved in Mexico for Prostate Cancer Therapy

https://weizmann-usa.org/news-media/news-releases/weizmann-institute-drug-tookad-soluble-approved-in-mexico-for-prostate-cancer-therapy/

Jan 04, 2016... Magnetic resonance images of the prostate gland after treatment with TOOKAD® Soluble. The black regions show the portions of the prostate where cancer was identified and eliminated by the therapy.
REHOVOT, ISRAEL—January 4, 2016—A therapy invented at the Weizmann Institute of Science and clinically developed in collaboration with Steba Biotech (Luxembourg) has been approved by Cofepris, Mexico’s health authority, for the focal treatment of early-stage prostate cancer.

TAGS: Cancer, Cancer treatment, Clinical trials

TOOKAD<sup>®</sup>, Invented at the Weizmann Institute of Science, Gains European Approval for Prostate Cancer
TOOKAD<sup>®</sup>, Invented at the Weizmann Institute of Science, Gains European Approval for Prostate Cancer

https://weizmann-usa.org/news-media/news-releases/tookad-invented-at-the-weizmann-institute-of-science-gains-european-approval-for-prostate-cancer/

Apr 29, 2019... TOOKAD® optic fibers illuminate only the cancerous regions, leaving healthy tissue alone
REHOVOT, ISRAEL—April 29, 2019—Steba Biotech, a privately owned company, has, in collaboration with scientists at the Weizmann Institute of Science, conducted extensive research and development on the prostate cancer treatment TOOKAD® – and now has received marketing authorization to make it available in 31 European countries. Following this regulatory approval, the first patients are currently being treated in top Israeli, German, English, and Italian medical centers.

TAGS: Cancer, Cancer treatment, Clinical trials

Hillel’s Tech Corner: Revolutionizing the Flu Shot
Hillel’s Tech Corner: Revolutionizing the Flu Shot

https://weizmann-usa.org/news-media/in-the-news/hillel-s-tech-corner-revolutionizing-the-flu-shot/

Jul 25, 2019... BiondVax
A universal flu vaccine is the key to combating the ever-mutating flu virus, but did we ever really stop to think about whether there is a better way?
The flu virus, or influenza, is far more than a week-long inconvenience that pulls us away from our commitments, although that, in and of itself, is pretty annoying. The flu can get deadly fast. According to the World Health Organization, influenza kills up to 650,000 people each year. Read that number again. In the US alone, the flu kills about 12,000 people in mild years, and up to 56,000 people in the more severe years, according to the Center for Disease Control.

TAGS: Immune system, Virus, Proteins, Clinical trials

Keeping Men Healthy, the Weizmann Way
Keeping Men Healthy, the Weizmann Way

https://weizmann-usa.org/news-media/feature-stories/keeping-men-healthy-the-weizmann-way/

Jun 07, 2016... Keeping Men Healthy, the Weizmann Way

TAGS: Cancer, Cancer treatment, Clinical trials, Fertility

Lighting the Way for a New Cancer Treatment
Lighting the Way for a New Cancer Treatment

https://weizmann-usa.org/news-media/feature-stories/lighting-the-way-for-a-new-cancer-treatment/

Jul 01, 2006... Research led by Prof. Avigdor Scherz of the Weizmann Institute of Science Department of Plant Sciences and Prof. Yoram Salomon of the Institute’s Department of Biological Regulation, Israel, is coming to fruition in a potential new treatment for prostate cancer. “This therapy requires knowledge of physics, chemistry and biology, as well as scientific methods of the twenty-first century,” Prof. Scherz said during a recent visit to the offices of the American Committee for the Weizmann Institute of Science (ACWIS) in New York.

TAGS: Cancer, Cancer treatment, Clinical trials

Research on Aging at the Weizmann Institute
Research on Aging at the Weizmann Institute

https://weizmann-usa.org/news-media/feature-stories/research-on-aging-at-the-weizmann-institute/

Aug 01, 2012... According to the World Health Organization (WHO), in 1900, the global average life span was 31 years of age. By 2030, in highly developed places such as the U.S., average life expectancy at birth is expected to be around 85. And while wisdom may come with age, so do many unwanted issues, such as poor physical and mental health. In addition, an aging population takes a toll on society: older people are often harder to treat medically; it can be more challenging to get around, either on foot or by driving; and general quality of life may be reduced.

TAGS: Cancer, Humanity, Cancer treatment, Clinical trials, Alzheimers

Brain’s Immune System “Key to Reversing Dementia”
Brain’s Immune System “Key to Reversing Dementia”

https://weizmann-usa.org/news-media/in-the-news/brain-s-immune-system-key-to-reversing-dementia/

Aug 18, 2015... New research gives hope to those suffering with dementia
Leading neurobiologist Professor Michal Schwartz said the findings were “very exciting” – and showed for the first time that a diseased brain was able to fight the debilitating condition.
Scientists saw a significant drop in the symptoms of dementia when they reduced the cells that prevent the immune system from reacting.
The study by experts at the Weizmann Institute of Science in Israel and published in journal Nature Communications, offers hope of a drug for the disease which affects about 850,000 people in Britain.

TAGS: Neuroscience, Immune system, Immunotherapy, Clinical trials, Alzheimers

Teaming Up to Defeat Prostate Cancer
Teaming Up to Defeat Prostate Cancer

https://weizmann-usa.org/news-media/feature-stories/teaming-up-to-defeat-prostate-cancer/

May 28, 2015... Prostate cancer is the second most common type of cancer – and the second leading cause of cancer-related deaths – among American men. According to the Centers for Disease Control and Prevention (CDC), one in six men will be diagnosed with prostate cancer during his lifetime.
Three leading researchers in this field – Prof. Avigdor Scherz of the Department of Plant Sciences at Israel’s Weizmann Institute of Science; Dr. Peter Scardino, Chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City; and Dr. Peter Schulam, Chair of the Department of Urology at the Yale School of Medicine, New Haven – agree that safer, more effective detection methods and treatments are needed for the more than 240,000 men diagnosed with prostate cancer each year. Speaking at an event co-sponsored by the New York Region of the American Committee for the Weizmann Institute of Science and the Association of Yale Alumni in Medicine, the researchers described the current state of prostate cancer diagnosis and therapy and discussed their collaboration on a highly promising new treatment.

TAGS: Cancer, Cancer treatment, Clinical trials

Steba Offers Prostate Cancer Patients a Better Approach
Steba Offers Prostate Cancer Patients a Better Approach

https://weizmann-usa.org/news-media/in-the-news/steba-offers-prostate-cancer-patients-a-better-approach/

Jun 06, 2016... Last month a new treatment was revealed - invented in Israel at the Weizmann Institute - which is making its way to the public. The company leading the commercialization of the technology is Steba Biotech, led by a Jewish father-son team from France who previously owned one of the largest private pharmaceutical companies in the country.
Raphael and Fabrice Harari sold a significant portion of their previous business ventures to fund their vision for Steba; they even rejected, they say, an investment based on a valuation of more than a billion dollars - because of their Zionism.

TAGS: Culture, Cancer treatment, Clinical trials

Prostate and Ovarian Cancer: What Weizmann is Doing
Prostate and Ovarian Cancer: What Weizmann is Doing

https://weizmann-usa.org/news-media/feature-stories/prostate-and-ovarian-cancer-what-weizmann-is-doing/

Sep 07, 2016... Prostate and Ovarian Cancer: What Weizmann is Doing

TAGS: Culture, Cancer, Cancer treatment, Clinical trials

First 1 2 3 4 Last
Back Next
SHARE

Our Achievements

Learn more about remarkable Weizmann Institute achievements that are enhancing and transforming our lives.

Learn More

Support Our Flagship Projects

Help us accelerate exciting initiatives in three forward-looking fields: neuroscience, physics, and artificial intelligence.

Donate Now

Newsletter

Get the latest news and breakthroughs from the Weizmann Institute of Science.

About Us
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
Our Achievements
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Get Involved
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
News & Media Blog: Curiosity Review Donate Now Contact Us
Privacy Policy Gift Acceptance Policy Financial Information

©2023 American Committee for the Weizmann Institute of Science

Charity Navigator

FOR THE FOURTH CONSECUTIVE YEAR

Platinum Transparency 2023